Achilles Therapeutics PLC (ACHL)
1.06
-0.01
(-0.93%)
USD |
NASDAQ |
Nov 22, 14:06
Achilles Therapeutics Total Liabilities (Quarterly): 19.54M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 19.54M |
| June 30, 2024 | 15.71M |
| March 31, 2024 | 15.39M |
| December 31, 2023 | 19.09M |
| September 30, 2023 | 21.85M |
| June 30, 2023 | 24.06M |
| March 31, 2023 | 22.46M |
| December 31, 2022 | 23.31M |
| Date | Value |
|---|---|
| September 30, 2022 | 24.73M |
| June 30, 2022 | 26.13M |
| March 31, 2022 | 25.74M |
| December 31, 2021 | 27.58M |
| September 30, 2021 | 24.89M |
| June 30, 2021 | 29.52M |
| March 31, 2021 | 27.05M |
| December 31, 2020 | 29.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.39M
Minimum
Mar 2024
29.55M
Maximum
Dec 2020
23.54M
Average
24.40M
Median
Total Liabilities (Quarterly) Benchmarks
| Autolus Therapeutics PLC | 350.52M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Centessa Pharmaceuticals PLC | 110.58M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Verona Pharma PLC | 251.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.68M |
| Shareholders Equity (Quarterly) | 103.14M |